Galicia's Cancer Screening Programs Show Promising Results

Cancer screening programs in Galicia have achieved remarkable success rates, with a notable increase in early detection of breast, colon, and cervical cancers. The Deputy Director General of Healthy Lifestyles, Sagrario Pérez, highlighted the efficacy of these programs during the "Let's Talk About Cancer" conference. Key takeaways from the conference include the implementation of new screening programs and the expansion of existing ones, such as the inclusion of women aged 25 to 35 in cervical screening. The consolidated screening programs have been taken to prisons, increasing accessibility for all segments of the population.

Key Takeaways:

  • The breast cancer screening program achieved a participation rate of 84.6% in 2024, with 891 cancers diagnosed, of which 70% were in early or initial stages.
  • The colon cancer screening program had 8,608 people undergo colonoscopies in 2024, with 34% having some type of lesion, including 256 cancers and 3,180 follow-up lesions.
  • The cervical cancer screening program had an effective participation rate of 60% by December 2024, with 63 cancers diagnosed, of which 88% presented stages I and II.
  • The Xunta announced the incorporation of women aged 25 to 35 into cervical screening next year, expanding the reach of the program.
  • The already consolidated screening programs will be taken to prisons, increasing accessibility and promoting early cancer detection among this population.
  • The participation rate for breast cancer screening increased significantly, with 891 cancers diagnosed in 2024, a marked improvement from previous years.
  • The colon cancer screening program saw a 65.8% identification rate of cancers in early stages, highlighting the effectiveness of the program.
  • The cervical cancer screening program showed a notable increase in effective participation, reaching 60% by December 2024, with 88% of diagnosed cancers presenting in stages I and II.

Statistics:

  • 84.6% participation rate for breast cancer screening in 2024.
  • 891 cancers diagnosed in 2024, with 70% in early or initial stages.
  • 8,608 people underwent colonoscopies in 2024, with 34% having some type of lesion.
  • 256 cancers and 3,180 follow-up lesions detected in the colon cancer screening program.
  • 60% effective participation rate in cervical cancer screening by December 2024.
  • 63 cancers diagnosed in the cervical cancer screening program, with 88% presenting in stages I and II.

Sources:

  • Xunta de Galicia.
  • USC Chair of Healthy Living.